Trial Profile

A Phase 2 Open-Label Study of HTX-011 Via Individualized Dosing Administration for Postoperative Analgesia Following Unilateral Simple Bunionectomy

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 29 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bupivacaine/meloxicam (Primary) ; Aprepitant; Ibuprofen; Paracetamol
Indications Postoperative pain
Focus Therapeutic Use
Sponsors Heron Therapeutics

Most Recent Events

21 Jan 2021 According to a Heron Therapeutics media release, data presented at Journal of the American Podiatric Medical Association.
21 Jan 2021 Results presented in a Heron Therapeutics Media Release.
21 Jan 2021 According to a Heron Therapeutics media release, data published in Journal of the American Podiatric Medical Association.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com